These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16893693)

  • 1. Outcome after acute incomplete sirolimus-eluting stent apposition as assessed by serial intravascular ultrasound.
    Kimura M; Mintz GS; Carlier S; Takebayashi H; Fujii K; Sano K; Yasuda T; Costa RA; Costa JR; Quen J; Tanaka K; Lui J; Weisz G; Moussa I; Dangas G; Mehran R; Lansky AJ; Kreps EM; Collins M; Stone GW; Moses JW; Leon MB
    Am J Cardiol; 2006 Aug; 98(4):436-42. PubMed ID: 16893693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute coronary syndrome is an independent risk factor for late incomplete stent apposition after sirolimus-eluting stent implantation.
    Zhang RY; DU R; Zhu ZB; Zhang Q; Hu J; Lü AK; Zhang JS; Shen WF
    Chin Med J (Engl); 2008 Dec; 121(24):2504-8. PubMed ID: 19187586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late incomplete apposition after drug-eluting stent implantation: incidence and potential for adverse clinical outcomes.
    Siqueira DA; Abizaid AA; Costa Jde R; Feres F; Mattos LA; Staico R; Abizaid AA; Tanajura LF; Chaves A; Centemero M; Sousa AG; Sousa JE
    Eur Heart J; 2007 Jun; 28(11):1304-9. PubMed ID: 17478457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up of incomplete stent apposition in patients who received sirolimus-eluting stent for de novo coronary lesions: an intravascular ultrasound analysis.
    Degertekin M; Serruys PW; Tanabe K; Lee CH; Sousa JE; Colombo A; Morice MC; Ligthart JM; de Feyter PJ
    Circulation; 2003 Dec; 108(22):2747-50. PubMed ID: 14638542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of Late-Acquired Incomplete Stent Apposition: A Comparison With First-Generation and Second-Generation Drug-Eluting Stents.
    Waseda K; Ako J; Kume T; Fitzgerald PJ; Honda Y
    J Invasive Cardiol; 2016 Aug; 28(8):323-9. PubMed ID: 26689416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Frequency and characteristics of incomplete stent apposition during and after sirolimus-eluting stent implantation].
    Takeuchi H; Morino Y; Fujibayashi D; Hashida T; Kawamura Y; Tsumuraya N; Okamoto N; Nagaoka M; Ikari Y; Tanabe T
    J Cardiol; 2007 Aug; 50(2):111-8. PubMed ID: 17802694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late incomplete stent apposition after sirolimus-eluting stent implantation: a serial intravascular ultrasound analysis.
    Ako J; Morino Y; Honda Y; Hassan A; Sonoda S; Yock PG; Leon MB; Moses JW; Bonneau HN; Fitzgerald PJ
    J Am Coll Cardiol; 2005 Sep; 46(6):1002-5. PubMed ID: 16168282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of postprocedure minimum stent area on long-term results following abciximab-coated stent implantation: an intravascular ultrasound analysis.
    Hong YJ; Jeong MH; Hwang SH; Yun NS; Lim SY; Lee SR; Hong SN; Kim KH; Park HW; Kim JH; Kim W; Ahn YK; Cho JG; Park JC; Kang JC
    Int J Cardiol; 2007 Dec; 123(1):23-8. PubMed ID: 17289173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The fate of incomplete stent apposition with drug-eluting stents: an optical coherence tomography-based natural history study.
    Ozaki Y; Okumura M; Ismail TF; Naruse H; Hattori K; Kan S; Ishikawa M; Kawai T; Takagi Y; Ishii J; Prati F; Serruys PW
    Eur Heart J; 2010 Jun; 31(12):1470-6. PubMed ID: 20363765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms, pathophysiology, and clinical aspects of incomplete stent apposition.
    Attizzani GF; Capodanno D; Ohno Y; Tamburino C
    J Am Coll Cardiol; 2014 Apr; 63(14):1355-67. PubMed ID: 24530675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between sirolimus-eluting stents and intracoronary catheter-based beta radiation for the treatment of in-stent restenosis.
    Feres F; Muñoz JS; Abizaid A; Albertal M; Mintz GS; Staico R; Centemero M; Mattos LA; Maldonado G; Tanajura LF; Chaves A; Pinto I; Abizaid AS; Seixas AC; Vaz VD; Sousa A; Sousa JE
    Am J Cardiol; 2005 Dec; 96(12):1656-62. PubMed ID: 16360353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiographic and intravascular ultrasound study of the effects of overlapping sirolimus- and paclitaxel-eluting stents: comparison with same drug-eluting overlapping stents.
    Kang WC; Oh KJ; Han SH; Ahn TH; Chung WJ; Shin MS; Koh KK; Choi IS; Shin EK
    Int J Cardiol; 2007 Dec; 123(1):12-7. PubMed ID: 17289176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of late incomplete stent apposition after sirolimus-eluting stent implantation on 4-year clinical events: intravascular ultrasound analysis from the multicentre, randomised, RAVEL, E-SIRIUS and SIRIUS trials.
    Hoffmann R; Morice MC; Moses JW; Fitzgerald PJ; Mauri L; Breithardt G; Schofer J; Serruys PW; Stoll HP; Leon MB
    Heart; 2008 Mar; 94(3):322-8. PubMed ID: 17761505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of edge stenosis following sirolimus-eluting stent deployment (a quantitative intravascular ultrasound analysis from the SIRIUS trial).
    Sakurai R; Ako J; Morino Y; Sonoda S; Kaneda H; Terashima M; Hassan AH; Leon MB; Moses JW; Popma JJ; Bonneau HN; Yock PG; Fitzgerald PJ; Honda Y;
    Am J Cardiol; 2005 Nov; 96(9):1251-3. PubMed ID: 16253592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sirolimus-eluting stent in chronic total occlusion: the SICTO study.
    Lotan C; Almagor Y; Kuiper K; Suttorp MJ; Wijns W
    J Interv Cardiol; 2006 Aug; 19(4):307-12. PubMed ID: 16881976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of sirolimus-eluting stent implantation for the treatment of ostial left anterior descending artery stenosis with intravascular ultrasound guidance.
    Seung KB; Kim YH; Park DW; Lee BK; Lee CW; Hong MK; Kim PJ; Chung WS; Tahk SJ; Park SW; Park SJ
    J Am Coll Cardiol; 2005 Sep; 46(5):787-92. PubMed ID: 16139126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiographic results of the first human experience with the Biolimus A9 drug-eluting stent for de novo coronary lesions.
    Costa RA; Lansky AJ; Abizaid A; Müeller R; Tsuchiya Y; Mori K; Cristea E; Leon MB; Sousa JE; Schmidt T; Hauptmann KE; Grube E
    Am J Cardiol; 2006 Aug; 98(4):443-6. PubMed ID: 16893694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of intravascular ultrasound lesion characteristics on neointimal hyperplasia following sirolimus-eluting stent implantation.
    Kaneda H; Koizumi T; Ako J; Terashima M; Morino Y; Honda Y; Yock PG; Leon MB; Moses JW; Fitzgerald PJ
    Am J Cardiol; 2005 Nov; 96(9):1237-41. PubMed ID: 16253589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of incomplete stent apposition on long-term clinical outcome after drug-eluting stent implantation.
    Cook S; Eshtehardi P; Kalesan B; Räber L; Wenaweser P; Togni M; Moschovitis A; Vogel R; Seiler C; Eberli FR; Lüscher T; Meier B; Jüni P; Windecker S
    Eur Heart J; 2012 Jun; 33(11):1334-43. PubMed ID: 22285579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.